Cogent Biosciences (COGT) Insider Trading & Ownership $12.10 -0.27 (-2.22%) As of 12:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cogent Biosciences (NASDAQ:COGT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.29%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$25.00MNumber OfInsiders Selling(Last 12 Months)0 Get COGT Insider Trade Alerts Want to know when executives and insiders are buying or selling Cogent Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COGT Insider Buying and Selling by Quarter Cogent Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/10/2025Fairmount Funds Management LlcDirectorBuy2,777,777$9.00$24,999,993.00 (Data available from 1/1/2013 forward) COGT Insider Trading Activity - Frequently Asked Questions Who is on Cogent Biosciences' Insider Roster? The list of insiders at Cogent Biosciences includes Fairmount Funds Management Llc. Learn more on insiders at COGT. What percentage of Cogent Biosciences stock is owned by insiders? 7.29% of Cogent Biosciences stock is owned by insiders. Learn more on COGT's insider holdings. Which Cogent Biosciences insiders have been buying company stock? The following insider purchased COGT shares in the last 24 months: Fairmount Funds Management Llc ($24,999,993.00). How much insider buying is happening at Cogent Biosciences? Insiders have purchased a total of 2,777,777 COGT shares in the last 24 months for a total of $24,999,993.00 bought. Cogent Biosciences Key ExecutivesMr. Andrew R. Robbins M.B.A. (Age 48)President, CEO & Director Compensation: $1.06MDr. John Edward Robinson Ph.D. (Age 49)Chief Scientific Officer Compensation: $749.89kDr. Jessica Sachs M.D. (Age 49)Chief Medical Officer Compensation: $773.92kMr. John L. Green C.A. (Age 44)CPA, CFO & Principal Accounting Officer Compensation: $763.99kMr. Brad BarnettChief Technology OfficerChristi WaarichSenior Director of Investor RelationsMr. Evan D. Kearns J.D. (Age 44)Chief Legal Officer & Corporate Secretary Ms. Erin SchellhammerChief People OfficerMr. Dana R. Martin Pharm.D.Senior VP of Medical Affairs & Chief Patient OfficerBrad FellSenior Vice President of Chemistry More Insider Trading Tools from MarketBeat Related Companies CRISPR Therapeutics Insider Selling Vaxcyte Insider Selling Cytokinetics Insider Selling ADMA Biologics Insider Selling Krystal Biotech Insider Selling Akero Therapeutics Insider Selling Avidity Biosciences Insider Selling PTC Therapeutics Insider Selling Arcellx Insider Selling Merus Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:COGT) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | SponsoredWhy Elon put $51 million into thisEvery major AI breakthrough comes with a catch: It burns through power like jet fuel. Now Google, Microsof...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
